Command Palette

Search for a command to run...

Demo mode
All companies

Abridge

Ambient AI that turns clinician-patient conversations into notes, billing-ready documentation, and point-of-care intelligence.

Clinical AI & DocumentationClinical Documentation AIFounded 2018 · Pittsburgh, PA, USA (large office in San Francisco)Website

Updated 3d ago

Valuation

$5.3B

as of Apr 2026

Total raised

$830M

Series E extension (reported)

Est. revenue

$117M

~2025

Momentum

9/10

Maturity

7/10

Headcount

~600

Valuation trajectory
Disclosed post-money valuation at each round
Business focus

Ambient AI clinical documentation and, increasingly, a full "care intelligence" platform for health systems. Abridge's core product listens to clinician-patient conversations and generates structured, EHR-integrated clinical notes in real time (deeply embedded in Epic, plus Oracle Health and athenahealth), supporting 100M+ patient conversations projected for 2026 across 270+ of the largest US health systems. It has expanded into billing-ready documentation and coding (Contextual Reasoning Engine; #1 Best in KLAS 2026 for Ambient AI including RCM use), real-time prior authorization with utilization-management network Availity, nursing/inpatient/ED workflows, clinical decision support built on licensed evidence (NEJM Group, JAMA Network, American Diabetes Association, Journal of Clinical Oncology), and clinical-trial eligibility screening (Eli Lilly). Marquee customers include Kaiser Permanente (24,600 physicians), Mayo Clinic, Johns Hopkins, Duke, UPMC (12,000+ clinicians), Sutter Health, Yale New Haven, Northwestern, Emory, and HonorHealth.

Revenue model

Enterprise B2B SaaS sold to health systems: per-clinician annual subscriptions (roughly $2,000-2,500/clinician/year per Sacra), priced by user count and encounter volume; expanding into revenue-cycle/coding modules and payer-facing prior-authorization workflows (Availity partnership) that tie pricing to billing value, plus an emerging pharma revenue stream (Eli Lilly trial-screening partnership).

Best sourced figures: $117M contracted ARR reported Q1 2025 (CNBC via LinkedIn/Sacra) and ~$100M run-rate ARR per Sacra (May 2025), up from ~$60M at end of 2024. Mid-2026 ARR is undisclosed but likely materially higher given growth to 270+ health systems (company, May 2026) and 100M+ conversations projected for 2026; no reliable 2026 revenue figure exists. Funding note: Fortune (Jun 2026) states ~$830M total raised, which does not fully reconcile with summing announced rounds plus the reported $316M April 2026 extension (Sacra/Forge secondary-source figure, reportedly a16z-led with NVentures, Lightspeed, and Bessemer participating; never company-confirmed) — treat the extension amount and total with caution. Fact-check (Jul 2026): Fortune independently reports both the $316M April 2026 extension at $5.3B and the ~$830M total; Tracxn/PitchBook show $778-780M over 8 rounds, so the total-raised discrepancy persists across data providers. Headcount updated to ~600 per Tracxn (605 employees as of May 31, 2026). Implied multiple at $5.3B is roughly 45-50x ARR.

Strategy

Stated: move "beyond the scribe" to a unified, AI-native clinician intelligence platform connecting clinics, insurers, and drugmakers — documentation as the wedge, then monetize the same conversation data for coding/billing, real-time prior authorization (Availity), payer adjudication, clinical decision support (NEJM/JAMA/ADA/JCO), and trial recruitment (Lilly). Rao frames it as changing how care is "delivered, experienced, and paid for." Inferred: (1) out-run commoditization of scribing by owning the clinical-conversation data layer and a NVIDIA Nemotron-based clinical model; (2) reduce Epic dependence after Epic ended the Workshop program and launched a competing scribe — hence direct payer (Availity, dedicated payer-vertical team now hiring) and pharma channels that Epic cannot intermediate; (3) lock in enterprise health systems via system-wide contracts (UPMC 12,000 clinicians, HonorHealth enterprise rollout) before Epic/Microsoft close the gap; (4) prep for IPO — Instacart's ex-CFO, ex-Slack/Notion CTO for infrastructure scale, brand repositioned from point solution to healthcare's "operating system."

Moat

Largest proprietary corpus of real-world clinician-patient conversations (100M+ encounters projected in 2026 across 270+ health systems), compounding via a purpose-built clinical model co-developed with NVIDIA (fine-tuned Nemotron on de-identified Abridge data); enterprise-wide contracts with the most complex health systems and auditable in-EHR workflows create high switching costs; strategic customers-as-investors (Kaiser, Mayo, CVS, UPMC) align incentives; the new payer rail (Availity real-time prior auth) adds a two-sided network rivals lack. The moat is real but contested — Epic ended the Workshop program that housed Abridge's flagship integration and now ships its own scribe, so the workflow layer is exactly where Epic and Microsoft are attacking, and the model layer leans on NVIDIA's open-weights base.

Future bets

Revenue-cycle and payer-side automation: billing-ready notes, coding, and real-time prior authorization/medical-necessity review inside the visit via the Availity network

high

Contextual Reasoning Engine targets billable notes; #1 Best in KLAS 2026 covered ambient AI in RCM; the Jan 2026 Availity partnership (announced at JPM) operationalizes payer determination during the encounter. RCM and UM budgets are far larger and stickier than scribe budgets.

A dedicated payer vertical — selling directly to insurers, not just providers

high

Abridge job postings explicitly recruit for a 'New Verticals' team building out the payer vertical (product discovery, payer customer engagement, early commercialization), and the company describes itself as building 'real-time bridges between patients, providers, and payers.' A payer-funded revenue line hedges both Epic dependence and provider budget cycles.

Point-of-care clinical decision support built on licensed gold-standard evidence

high

2026 partnerships with NEJM Group, JAMA Network, the American Diabetes Association, and the Journal of Clinical Oncology move Abridge from passive documentation into active guidance during the visit — a direct answer to OpenEvidence and a way to justify platform pricing.

Proprietary clinical-conversation model with NVIDIA (fine-tuned Nemotron) reducing general-purpose LLM dependence

high

Announced June 2026: Abridge trains and fine-tunes on NVIDIA's open-weights Nemotron family using its own de-identified conversation data — controlling cost, differentiation, and the safety story while weaponizing the data moat, though not a fully from-scratch foundation model.

Pharma as a second customer base: clinical-trial eligibility screening inside clinical conversations

medium

Eli Lilly strategic investment and partnership (June 2026); trial recruitment is a multi-billion-dollar pain point and monetizes the same data with non-provider dollars.

Inpatient, ED, nursing, and ambient 'smart hospital' coverage across the full stay, including virtual care

medium

Artisight (room sensors) and Hellocare (virtual care) integrations extend ambient documentation beyond ambulatory visits; Abridge Inside for Emergency Medicine, the Epic/Mayo nursing collaboration, and UPMC's 12,000-clinician enterprise rollout all point the same direction. Massive engineering hiring under a hyperscale-pedigree CTO supports the platform build-out.

Recent moves

2026

UPMC committed to scaling Abridge to 12,000+ clinicians across 40+ hospitals; HonorHealth went enterprise-wide; customer base includes Mayo Clinic, Johns Hopkins, Duke, Sutter, Yale New Haven, Northwestern, Emory

Jun 2026

Keynote unveiled unified AI-native 'clinician intelligence platform' spanning documentation, billing, decision support, payer workflows, and trial screening; announced NVIDIA co-development of a clinical-conversation model (fine-tuned open-weights Nemotron on Abridge's de-identified data), Eli Lilly strategic investment plus trial-eligibility screening, Artisight smart-hospital and Hellocare virtual-care integrations, and content partnerships with the American Diabetes Association and Journal of Clinical Oncology

May 2026

Named San Oo (ex-Slack, Notion engineering leader; ex-ShopBack CTO) as CTO to scale infrastructure and agentic AI; company cited 270+ of the largest US health systems and 100M+ conversations projected for 2026; Zachary Lipton continues leading science

Apr 2026

Announced clinical decision support partnerships with NEJM Group and JAMA Network; reportedly closed a $316M Series E extension at a flat $5.3B valuation (per Sacra/Forge secondary data, a16z-led with NVentures, Lightspeed, Bessemer; not company-confirmed)

Feb 2026

Won #1 Best in KLAS 2026 for Ambient AI (including revenue-cycle use); Epic simultaneously launched its own competing AI scribe, prompting Abridge to publicly reposition as 'more than an AI scribe' (STAT)

Jan 2026

Partnered with Availity at JPM 2026 to embed real-time prior authorization and medical-necessity review into the clinical conversation — first concrete payer-side product motion

2025

Hired Sagar Sanghvi, former Instacart CFO, as chief financial officer — widely read as pre-IPO positioning

Oct 2025

Epic announced it is ending the Workshop (formerly Partners and Pals) co-development program that housed Abridge's flagship integration, saying ambient voice recognition is now 'mature' — removing Abridge's privileged 'first Pal' position (Axios)

Sep 2025

Business Insider expose detailed the increasingly adversarial Epic-Abridge relationship ('healthcare's messiest relationship') as Epic readied its own scribe

Jun 2025

Raised $300M Series E led by Andreessen Horowitz with Khosla Ventures at $5.3B — valuation doubled in four months; 150+ health systems live

Feb 2025

Raised $250M Series D co-led by Elad Gil and IVP at $2.75B post-money; announced Contextual Reasoning Engine for billable, compliant notes; surpassed 100 health-system deployments (incl. Kaiser Permanente rollout to 24,600 physicians); launched Abridge Inside for Emergency Medicine within Epic's Workshop program

Key people

Shiv Rao, MDCo-founder & CEO

Practicing non-invasive cardiologist; previously led innovation investing at UPMC Enterprises before founding Abridge in 2018.

San OoChief Technology Officer (hired May 2026)

Former senior engineering leader at Notion and Slack (joined Slack via its Astro Technology acquisition); ex-CTO of APAC unicorn ShopBack. Hired May 2026 to scale infrastructure, reliability, platform engineering, and agentic AI systems as Abridge moves deeper into clinical and payer workflows.

Zachary Lipton, PhDChief Scientist (previously CTO & Chief Scientist)

Associate professor of machine learning at Carnegie Mellon; ex-Amazon AI researcher; leads Abridge's AI research and the NVIDIA Nemotron-based clinical-conversation model work. Held the combined CTO & Chief Scientist role until San Oo's May 2026 CTO hire.

Sagar SanghviCFO

Former CFO of Instacart, where he helped take the company public; hired in 2025 in a move widely read as IPO preparation.

Julia ChouCOO

Former Google executive; runs operations and enterprise deployment across 270+ health systems.

Mario QueirozChief Product Officer

Former Google VP (Chromecast, Pixel); leads product as Abridge expands beyond scribing into a clinician intelligence platform.

Brian WilsonChief Commercial Officer

Healthcare enterprise-sales veteran driving Abridge's health-system land-and-expand motion.

Strengths
  • Category leader by deployment scale: 270+ of the largest US health systems, 100M+ conversations projected for 2026, #1 Best in KLAS 2026 for ambient AI
  • Blue-chip customer and strategic-investor flywheel (Kaiser, Mayo, CVS Health Ventures, NVIDIA NVentures, Eli Lilly, UPMC) that doubles as a sales channel
  • Proprietary de-identified dataset of medical conversations at unmatched scale, now feeding a clinical-conversation model co-developed with NVIDIA (Nemotron fine-tune)
  • First-mover position in payer-provider convergence: Availity partnership puts prior authorization and medical-necessity review inside the visit itself, a workflow no scribe rival owns yet
  • Elite research bench (CMU-anchored, led by Zachary Lipton) plus new hyperscale engineering leadership (San Oo, ex-Slack/Notion) for platform reliability and agentic AI
  • Massive war chest (~$830M raised) and IPO-caliber leadership additions (Instacart's ex-CFO, big-tech CTO/CPO/COO)
Weaknesses
  • Premium per-clinician pricing is exposed to commoditization as cheaper rivals (Nabla, Freed) and EHR-native scribes undercut it
  • Epic dependence has become adversarial: Epic ended the Workshop co-development program that housed Abridge's flagship integration (Oct 2025) while shipping its own competing scribe — the 'first Pal' advantage is largely gone
  • Valuation (~45-50x ARR at $5.3B) prices in flawless execution and multi-product expansion; the flat-valuation 2026 extension hints at a ceiling
  • Still largely a single-wedge (documentation) revenue base; RCM, payer, CDS, and pharma lines are early and unproven at scale
  • Foundation-model story rests on fine-tuning NVIDIA's open-weights Nemotron models rather than a fully proprietary stack, tempering the differentiation claim
  • Likely high cash burn from land-grab growth and heavy hiring (hundreds of open roles); profitability undisclosed
Risks
  • Epic turned from partner to competitor: it ended the Workshop/Pals co-development program (Oct 2025) and launched its own native AI scribe (early 2026), while Microsoft/Nuance DAX Copilot bundles scribing into existing contracts — threatening Abridge's core wedge, integration depth, and pricing
  • Ambient documentation is commoditizing fast (Nabla, Ambience, Suki, Freed), compressing per-clinician pricing
  • Expansion into clinical decision support and payer-facing automation (prior auth, medical-necessity review) raises regulatory (FDA/CMS) and malpractice-liability exposure
  • Patient-consent and privacy backlash against ambient recording (mainstream press now covering clinicians 'secretly' AI-tracking sessions) could trigger state-level consent rules that add deployment friction
  • $5.3B valuation at ~$100-120M ARR leaves little room for growth deceleration; the flat-valuation April 2026 extension suggests investors already see a ceiling
  • Health-system budget cycles and consolidation could slow enterprise expansion just as burn scales across five simultaneous product lines
Ecosystem

Competitors

Ambience HealthcareNablaSukiMicrosoft (Nuance DAX Copilot)Epic Systems (native scribe)OpenEvidenceCohere Health

Technologies

ambient voice AIASR for medical dialogueclinical-conversation model (NVIDIA Nemotron fine-tune)generative note summarizationEHR workflow integration (Epic, Oracle Health, athenahealth)medical coding / RCM automationreal-time prior authorization (FHIR, Availity network)clinical decision support with licensed evidenceclinical-trial eligibility screeninglinked evidence & auditabilityagentic AI infrastructure

Partnerships

Epic (deep integration; former first 'Pal' — Workshop program ended Oct 2025)NVIDIA (Nemotron-based clinical model co-development)Availity (real-time prior authorization)Eli Lilly (trial eligibility screening + strategic investment)Artisight (smart-hospital sensors)Hellocare (virtual care)NEJM GroupJAMA NetworkAmerican Diabetes AssociationJournal of Clinical OncologyMayo ClinicKaiser PermanenteUPMCJohns Hopkins MedicineDuke HealthSutter HealthYale New Haven HealthNorthwestern MedicineEmory HealthcareHonorHealthCVS HealthOracle Health (EHR integration)athenahealth (EHR integration)
Change history
Jul 8, 2026 · news

How nurses are shaping the next wave of clinical AI tools - Modern Healthcare (Modern Healthcare)

Jul 8, 2026 · news

Documentation Tools Aren’t Just for Doctors: Inside Reid Health’s Deployment of Abridge’s Nurse Tech - MedCity News (MedCity News)

Jul 5, 2026 · news

NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare (bing.com)

Jul 5, 2026 · news

Your mental health provider might be secretly tracking sessions with AI (bing.com)

Jul 5, 2026 · seed

Intelligence profile re-researched for Abridge.

Jul 5, 2026 · news

NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare - Yahoo Finance (Yahoo Finance)

Jul 5, 2026 · news

Abridge lays out road map for all-in-one clinical platform - Healthcare Brew (Healthcare Brew)

Jul 5, 2026 · news

Your mental health provider might be secretly tracking sessions with AI - Los Angeles Times (Los Angeles Times)

Sources
  1. axios.com/pro/health-tech-deals/2025/10/23/epic-ending-workshop-health-s
  2. beckershospitalreview.com/healthcare-information-technology/ai/epic-to-e
  3. businessinsider.com/inside-messiest-relationship-in-healthcare-ai-abridg
  4. healthcare-brew.com/stories/abridge-nvidia-eli-lilly-ai-clinical-platfor
  5. healthcare-brew.com/stories/q-and-a-with-abridges-new-clinician-scientis
  6. abridge.com/press-release/san-oo-cto
  7. healthcaredive.com/news/abridge-taps-new-technology-chief-san-oo/820766/
  8. fiercehealthcare.com/ai-and-machine-learning/jpm26-abridge-teams-availit
  9. abridge.com/press-release/abridge-availity-collaboration-announcement
  10. wsj.com/cio-journal/nvidia-is-developing-an-ai-healthcare-model-with-sta
  11. healthcaredive.com/news/abridge-nvidia-eli-lilly-investment-ai-platform-
  12. fortune.com/2026/06/11/abridge-operating-system-medicine-nvidia-eli-lill
  13. statnews.com/2026/02/10/abridge-ai-scribe-cto-talks-epic-microsoft-rebra
  14. techcrunch.com/2025/06/24/in-just-4-months-ai-medical-scribe-abridge-dou
  15. fortune.com/2025/02/17/exclusive-abridge-raises-250-million-series-d-led
  16. fiercehealthcare.com/ai-and-machine-learning/ambient-ai-startup-abridge-
  17. abridge.com/blog/series-e
  18. abridge.com/press-release/best-in-klas-2026-press
  19. abridge.com/press-release/upmc-scales-abridge
  20. sacra.com/c/abridge/
  21. techjacksolutions.com/ai-brief/abridge-closes-reported-316m-series-e-ext
  22. mobihealthnews.com/news/abridge-secures-300m-boosts-valuation-53b
  23. jobs.ashbyhq.com/abridge
  24. businesswire.com/news/home/20250129415917/en/Abridge-Inside-for-Emergenc
  25. finsmes.com/2020/10/abridge-raises-secures-15m-in-funding.html
  26. tracxn.com/d/companies/abridge-inc/__Pa9JE2faVUirY8e07Tb0M33vLUKKRf0BPr2